Long-term detection of SARS-CoV-2 antibodies after infection and risk of re-infection

por Hønge, Bo Langhoff, Hindhede, Lotte, Kaspersen, Kathrine Agergård, Harritshøj, Lene Holm, Mikkelsen, Susan, Holm, Dorte Kinggaard, Nilsson, Anna Christine, Sækmose, Susanne Gjørup, Sørensen, Erik, Aagaard, Bitten, Hjalgrim, Henrik, Jørgensen, Charlotte Sværke, Krause, Tyra Grove, Ullum, Henrik, Pedersen, Ole Birger Vestager, Ostrowski, Sisse Rye, Erikstrup, Christian
Publicado 2022

Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

por San-Juan, Rafael, Fernández-Ruiz, Mario, López-Medrano, Francisco, Carretero, Octavio, Lalueza, Antonio, Maestro de la Calle, Guillermo, Pérez-Jacoiste Asín, María Asunción, Bueno, Héctor, Caro-Teller, José Manuel, Catalán, Mercedes, de la Calle, Cristina, García-García, Rocío, Gómez, Carlos, Laguna-Goya, Rocío, Lizasoáin, Manuel, Martínez-López, Joaquín, Origüen, Julia, Sevillano, Ángel, Gutiérrez, Eduardo, de Miguel, Borja, Aguilar, Fernando, Parra, Patricia, Ripoll, Mar, Ruiz-Merlo, Tamara, Trujillo, Hernando, Pablos, José Luis, Paz-Artal, Estela, Lumbreras, Carlos, Aguado, José María
Publicado 2022

‘I don't want my son to be part of a giant experiment’: public attitudes towards COVID-19 vaccines in children

por Williams, S.N.
Publicado 2022

Return to work after COVID-19 infection – A Danish nationwide registry study

por Jacobsen, P.A., Andersen, M.P., Gislason, G., Phelps, M., Butt, J.H., Køber, L., Schou, M., Fosbøl, E., Christensen, H.C., Torp-Pedersen, C., Gerds, T., Weinreich, U.M., Kragholm, K.
Publicado 2022

The Low Yield of SARS-CoV-2 Rapid Antigen Testing in Screening Asymptomatic Hospital Visitors in Low-incidence Settings

por Boddeti, Nymisha L., Berezowski, Ivan, Taylor, Dania, Prajapati, Dhruvil, Patel, Jigar
Publicado 2022

Treatment with Tocilizumab in Adult Patients with Moderate to Critical COVID‐19 Pneumonia: A Single‐Center Retrospective Study

por Radulescu, Amanda, Istrate, Alexandru, Muntean, Monica
Publicado 2022

Contact tracing period and epidemiological characteristics of an outbreak of the SARS-CoV-2 Delta variant in Guangzhou

por Ma, Xiaowei, Wu, Keyi, Li, Yongguang, Li, Shunming, Cao, Lan, Xie, Huaping, Zheng, Jiazhen, Zhou, Rui, Yuan, Zelin, Huang, Zhiwei, Yuan, Jun, Wu, Xianbo
Publicado 2022

Characteristics and Outcomes of COVID-19 in Reproductive-Aged Pregnant and Nonpregnant Women in Osaka, Japan

por Zha, Ling, Sobue, Tomotaka, Hirayama, Atsushi, Takeuchi, Taro, Tanaka, Kenta, Katayama, Yusuke, Komukai, Sho, Shimazu, Takeshi, Kitamura, Tetsuhisa
Publicado 2022

COVID-19 and Lassa fever in Nigeria: A deadly alliance?

por Musa, Salihu Sabiu, Zhao, Shi, Abdullahi, Zainab Umar, Habib, Abdulrazaq Garba, He, Daihai
Publicado 2022

Bridging the gap for aesthetic training amidst the Covid-19 pandemic

por Martin, Serena, Khatib, Manaf, Reissis, Dimitris, Srinivasan, Jeyaram R.
Publicado 2022

Corrigendum to ‘An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccines ’ [International Journal of Infec...

por Liu, Binjian, Su, Xibin, Yu, George, Yang, Shuling, Wang, Feng, Huang, Tao, Zhou, Liuyong, Hui, Zhiqiang, Liao, Yixian, Qiu, Yuan, Huang, Juan, Gao, Hong, Liu, Justin, Zhong, Yaoqi
Publicado 2022

COVID-19 confinement impact on weight gain and physical activity in the older adult population: Data from the LOST in Lombardia study

por Stival, Chiara, Lugo, Alessandra, Bosetti, Cristina, Amerio, Andrea, Serafini, Gianluca, Cavalieri d’Oro, Luca, Odone, Anna, Stuckler, David, Iacoviello, Licia, Bonaccio, Marialaura, van den Brandt, Piet A., Zucchi, Alberto, Gallus, Silvano
Publicado 2022

The presence of anti–SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization

por Lippi, Giuseppe, Plebani, Mario
Publicado 2022

Reply to letter commenting on “Cosmetic tourism during the COVID-19 pandemic: Dealing with the aftermath”

por Varma, Parvathi, Kiely, John, Giblin, Anna Victoria
Publicado 2022

Serological reactivity of inactivated SARS-CoV-2 vaccine based on an S-RBD neutralizing antibody assay

por Zhang, Hui, Liu, Xingtian, Liu, Qingzhi, Mei, Hongshuang, Wang, Yashu, Cui, Gang, Zhao, Shuping
Publicado 2022

Virtual Infection Prevention and Control in Low- and Middle-Income Countries

por Jones, Tristan, Marimuthu, Kalisvar, Bearman, Gonzalo
Publicado 2022

SARS-CoV-2 transmission in opposition-controlled Northwest Syria: modeling pandemic responses during political conflict

por Marzouk, Manar, Alhiraki, Omar Alrashid, Aguas, Ricardo, Gao, Bo, Clapham, Hannah, Obaid, Wael, Altaleb, Hani, Almhawish, Naser, Rihawi, Hazem, Abbara, Aula, Douedari, Yazan, Hariri, Mahmoud, Howard, Natasha
Publicado 2022

Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for SARS‐CoV‐2 Variants after Primary and Booster Immunization

por Xie, Hui, Wen, Xiaojing, Li, Juan, Chen, Weixin, Chen, Meng, Zhang, Lichi, Lv, Min, Zhou, Shanshan, Bai, Shuang, Zhao, Wei, Wang, Jian, Wu, Jiang
Publicado 2022

Neutralizing antibody activity against the B.1.617.2 (delta) variant 8 months after two-dose vaccination with BNT162b2 in health care workers

por Benning, Louise, Morath, Christian, Bartenschlager, Marie, Reineke, Marvin, Töllner, Maximilian, Nusshag, Christian, Kälble, Florian, Reichel, Paula, Schaier, Matthias, Klein, Katrin, Schnitzler, Paul, Zeier, Martin, Süsal, Caner, Bartenschlager, Ralf, Speer, Claudius
Publicado 2022

From hydroxychloroquine to ivermectin: how unproven “cures” can go viral

por Taccone, Fabio Silvio, Hites, Maya, Dauby, Nicolas
Publicado 2022